Journal of Bone Oncology

Papers
(The H4-Index of Journal of Bone Oncology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Using β-Elemene to reduce stemness and drug resistance in osteosarcoma: A focus on the AKT/FOXO1 signaling pathway and immune modulation86
Fracture risk in breast cancer: Does obesity have an effect? A scoping review48
Role of the osteocyte in bone metastasis – The importance of networking44
Senescence in the bone marrow microenvironment: A driver in development of therapy-related myeloid neoplasms41
Impact of adjuvant imatinib on bone and muscle density in patients with resected gastrointestinal stromal tumors35
Is surgery without curettage effective for periacetabular Metastasis? Insights from a survival study of 93 patients32
Improved osteosarcoma survival with addition of mifamurtide to conventional chemotherapy – Observational prospective single institution analysis30
YBX1-interacting small RNAs and RUNX2 can be blocked in primary bone cancer using CADD52224
Automated measurement of lumbar pedicle screw parameters using deep learning algorithm on preoperative CT scans20
Study of imaging changes following preoperative denosumab for giant cell tumor of bone20
#37. Lactate-GPR81 signaling in acute myeloid leukemia (AML) contributes to bone marrow microenvironment dysfunction, macrophage polarization, and leukemia cell growth19
#43. Long-chain acyl-CoA synthetases support multiple myeloma cell proliferation, survival and mitochondrial function19
#9. Inhibition of the fatty acid binding proteins (FABPs) in myeloma cells modifies their lipid composition19
#45. Fatty acid binding proteins may modulate myeloma in Fabp4/5 double knockout mouse19
#21. PD-1 blockade induces bone loss and reduces bone strength in a breast cancer bone metastasis model19
#15. Single-cell discovery and multi-omic characterization of therapeutic targets in multiple myeloma17
#42. Local and systemic effects of Dickkopf-1 during breast cancer progression by limiting NK cell-mediated killing17
CDK4/6 inhibitor and doxorubicin synergistically inhibit breast cancer bone metastasis and enhance T-cell targeted therapy17
#33. PTHrP biological domains differentially regulate breast tumor intracrine signaling independent of nuclear localization17
0.031272888183594